The Motley Fool··Motley Fool YoutubeNovo Nordisk Stock Looks Cheap, But Execution Risks Cloud Recovery Outlook
Novo Nordisk stock trades cheap but faces execution headwinds versus Eli Lilly's superior operational performance in the booming GLP-1 market.
LLYNVOweight loss drugspharmaceutical competition